FDA DrugClass IINotable
FDA Recall: Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-
Description
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Hazard
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Remedy
N/A
Related Recalls
2026-08-05 · FDA_DRUG
FDA Recall: Dabigatran Etexilate Capsules, 75 mg, 30-count (3x10) blister pack, Rx only, Manufactured by: Alkem
Ascend Laboratories, LLC
2026-08-05 · FDA_DRUG
FDA Recall: Azelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Glenmark Pharma
Glenmark Pharmaceuticals Inc., USA
2026-08-05 · FDA_DRUG
FDA Recall: Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, Manuf
MICRO LABS USA INC
2026-08-05 · FDA_DRUG
FDA Recall: Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only,
MYLAN PHARMACEUTICALS INC